Tag: #Global Trends

Regulatory Update The UK government has announced major reforms to its clinical trial regulatory framework, set to take effect this... Read more

Research Update The U.S. Food and Drug Administration (FDA) has formally cleared the Investigational New Drug (IND) application for MH002,... Read more

Clinical News Bristol Myers Squibb (BMS) has announced successful top-line results from its Phase III SCOUT-HCM trial. This marks the... Read more

Investment Update U.K.-based Axol Bioscience, a specialist in induced pluripotent stem cell (iPSC) technologies, has secured $2.8 million (£2.1 million)... Read more

Strategic Spotlight At the 44th Annual J.P. Morgan Healthcare Conference, CEO Daniel O’Day outlined Gilead’s roadmap to sustain its dominance... Read more

Medical Spotlight At the 2026 J.P. Morgan Healthcare Conference, Sarepta Therapeutics CEO Douglas Ingram offered an optimistic outlook for the... Read more

Strategic Insight At the 2026 J.P. Morgan Healthcare Conference, CEO Robert Davis outlined MSD’s roadmap to safeguard its financial future... Read more

Growth Strategy At the 2026 J.P. Morgan Healthcare Conference, Vertex Pharmaceuticals CEO Reshma Kewalramani reaffirmed the company’s "five-in-five" goal: launching... Read more

R&D Strategic Focus At the 44th Annual J.P. Morgan Healthcare Conference, GSK’s Chief Scientific Officer Tony Wood detailed the company’s... Read more